3rd Quarter - Report

THE MCMANUS GROUP for GENENTECH

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Access and reimbursement in Medicare Parts B and D. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. S. 2764/H.R.5391 - Protecting Patient Access to Cancer and Complex Therapies Act H.R. 5378: Lower Costs More Transparency Act S. 3430: Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023 Issues related to Part D delinking of PBMs in H.R.2880 - Protecting Patients Against PBM Abuses Act, S.1967 - PBM Act, S. 2973 - The Modernizing and Ensuring PBM Accountability (MEPA) Act, H.R.8261 - Preserving Telehealth, Hospital, and Ambulance Access Act, H.R.7623 - Telehealth Modernization Act H.R.5547/S. 476 - Maintaining Investments in New Innovation Act

Foreign entity interest: 100% ownership by F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, SUI

LobbyistCovered position, as disclosed
JOHN MCMANUS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2973 (118th), S. 2764 (118th), H.R. 5378 (118th), H.R. 2880 (118th), S. 3430 (118th), H.R. 7623 (118th), S. 476 (118th), H.R. 8261 (118th), H.R. 5547 (118th), S. 1967 (118th), H.R. 5391 (118th)

Health Issues HCR

Issues related to reforming and increasing transparency within the 340B Drug Pricing Program including in H.R. 3290 - To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. H.R. 4421 - Preparing for All Hazards and Pathogens Reauthorization Act/S.2333 - Pandemic and All-Hazards Preparedness and Response Act H.R. 5378: Lower Costs, More Transparency Act, S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023 Issues related to commercial PBM Delinking, including House: DRUG ACT HR 6283, S. 1542. S.1375/H.R. 830 HELP Copays Act

Foreign entity interest: 100% ownership by F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, SUI

LobbyistCovered position, as disclosed
JOHN MCMANUS Staff Director W&M Health Subcommittee; LA, Rep. Bill Thomas

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4421 (118th), H.R. 830 (118th), S. 1542 (118th), H.R. 5378 (118th), S. 2333 (118th), S. 1375 (118th), S. 3430 (118th), H.R. 3290 (118th), H.R. 6283 (118th)

Taxation/Internal Revenue Code TAX

Issues related to research and development tax amortization in H.R. 2673 American Innovation and R&D competitiveness Act of 2023 H.R.7024 - Tax Relief for American Families and Workers Act of 2024 S.866 - American Innovation and Jobs Act

Foreign entity interest: 100% ownership by F. Hoffman-La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, SUI

LobbyistCovered position, as disclosed
JOHN MCMANUS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 866 (118th), H.R. 7024 (118th), H.R. 2673 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.